{{Rsnum
|rsid=3745522
|Gene=KLK15
|Chromosome=19
|position=50827676
|Orientation=plus
|GMAF=0.2925
|Gene_s=KLK15
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 55.4 | 38.5 | 6.2
| HCB | 15.3 | 51.9 | 32.8
| JPT | 33.0 | 52.3 | 14.7
| YRI | 93.7 | 6.3 | 0.0
| ASW | 80.4 | 17.9 | 1.8
| CHB | 15.3 | 51.9 | 32.8
| CHD | 17.8 | 50.5 | 31.8
| GIH | 45.0 | 47.0 | 8.0
| LWK | 91.7 | 8.3 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 77.4 | 21.3 | 1.3
| TSI | 68.3 | 26.7 | 5.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22132073
|Title=Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}